Equity
€74,673 from €158,446 in 2013
Equity fell by 53% in 12 years.
COBEA
Lifetime
20 annual accounts with figures on one time axis, 27 filings since 1999peak €72,907 (2010)
-€4,057▼ €10,058
lowest -€28,162 (2023)
-€5,219▼ €8,682
peak €158,446 (2013)
€74,673▼ 6.5%
€30,890▼ 19.4%
peak 0.8 FTE (2006)
-not published
Board2 names since 2011
2 directors and 1 other
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €6,000 to -€4,057Loss of €5,219Merger proposal: IMAGERIE MEDICALE HELMET takes over COBEA 12-12Change of role: , from manager to director 01-08Debts from €38,324 to €30,890Cash from €38,220 to €1,682
Key points
from the 2025 annual accountsRestructuring
2
2 restructurings in 2026. Latest: merger with COBEA.
Position in the sector
-€5,219
Lower net result than 94% of companies in human health. Sector median €59,563 · 21,317 companies.
Turnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Merger proposal: IMAGERIE MEDICALE HELMET takes over COBEA
The company holds all the shares of COBEA · Board meeting of 17-11-2025 · Gazette deed
Change of role: , from manager to director
General meeting of 22-07-2025 · Gazette deed
Reappointment: (manager)
General meeting of 09-05-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| COBEA Wavre | €105,563 | -€4,057 | 70.7% | - |
| Floriphar Waterloo | €113,104 | €447 | -32.5% | - |
| THALIA Grez-Doiceau | €132,673 | -€12,686 | 63.4% | - |
| DELANCEY Waterloo | €109,948 | -€901 | 99.8% | - |
| DANOS LABORATORY Ixelles | €297,522 | -€27,299 | 38.0% | - |
| CHROMETRA Kortenaken | €97,221 | -€21,760 | 28.7% | - |
| Oncurious Brussels | €160,462 | -€5,951 | 56.3% | - |
These companies have the same main activity as COBEA: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €97,200 and €298,000, founded between 1999 and 2015.
Official details
Source: KBO- Status
- Active since 18-03-1999Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Establishment unit
- 2.228.622.0151030 Schaerbeek, since 18-03-1999
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €105,563▼ 10.7%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on COBEA
COBEA files the micro format. That format states no turnover. The gross margin fell from €71,988 in 2006 to -€4,057 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about COBEA
- What is the company number of COBEA?
- The company number of COBEA is 0465.667.997. The VAT number is the same number with BE in front: BE 0465.667.997.
- Where is COBEA based?
- The registered office is at Avenue de la Croisée 7, 1300 Wavre.Company details
- What does COBEA do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of COBEA?
- COBEA is a private limited company (BV).
- When was COBEA founded?
- COBEA was founded on 18-03-1999.
- Is COBEA still active?
- Yes, COBEA is an active enterprise in the KBO register.
- What is the turnover of COBEA?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is COBEA profitable?
- In financial year 2025, COBEA made a loss of €5,219.
- Where can I find the annual accounts of COBEA?
- COBEA filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of COBEA due?
- COBEA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.